The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.

The FDA pushed back its decision date on Cytokinetics heart drug, while AstraZeneca got Phase 3 trial results that could help ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

Enrollment in the school-based asthma therapy program increased asthma control rates among children and decreased health care utilization.

During National Asthma and Allergy Awareness Month, the high prevalence and costs of allergies and asthma in the US are ...

AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for ...

AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) has met the ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Blood eosinophil count and fractional exhaled nitric oxide significantly enhance prognostic assessment of asthma attack risk.

with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in adults and children 6 years of age and older whose asthma is not ...

Sublingual isosorbide dinitrate, 5 mg, combined with oral propranolol, 40 mg, was given four times daily for six weeks to 23 patients with angina pectoris. The effects were compared with those of ...